Document is current
Any future updates will be listed below
-
Authors
Shah, Anika
Love, Jordan A.
Butler, Matthew
Butler, Lara N.
Mittendorf, Elizabeth A.
King, Tari A.
Park, Ko Un
- License Information
-
More Information
Article History
Received: 12 January 2026
Accepted: 1 March 2026
First Online: 13 March 2026
Disclosure
: Elizabeth A. Mittendorf reports compensated service on scientific advisory boards for Astra Zeneca, BioNTech, and Merck; uncompensated service on steering committees for Bristol Myers Squibb and Roche/Genentech; speakers honoraria and travel support from Merck Sharp and Dohme; and institutional research support from Roche/Genentech (via SU2C grant) and Gilead. She also reports research funding from Susan Komen for the Cure, for which she serves as a Scientific Advisor, and uncompensated participation as a member of the American Society of Clinical Oncology Board of Directors. Tari A. King declares speaker’s honoraria exact sciences, compensated advisory board service FES steering committee (GE Healthcare) and advisory board Prosigna (Veracyte); faculty Precisca cancer information service; advisory board Ataraxis AI.
